Clinical efficacy of thalidomide in multiple myeloma (MM), myelodysplastic syndromes (MDS) and histiocytosis

被引：0
|
作者：
Martinelli, G
Mingrone, W
Alietti, A
Ferrucci, F
Cocorocchio, E
Peccatori, F
Cinieri, S
Corsini, C
Zucca, E
Bertolini, F
机构：
[1] European Inst Oncol, Milan, Italy
[2] Oncol Inst So Switzerland, Bellinzona, Switzerland
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
F13
引用
收藏
页码：54 / 54
页数：1
相关论文
共 50 条
  • [1] Clinical efficacy and biologic activity of thalidomide in multiple myeloma (MM), myelodysplastic syndromes (MDS) and histiocytosis.
    Mingrone, W
    Alietti, A
    Ferrucci, F
    Cocorocchio, E
    Peccatori, F
    Cinieri, S
    Corsini, C
    Zucca, E
    Bertolini, F
    Martinelli, G
    ANNALS OF ONCOLOGY, 2000, 11 : 96 - 96
  • [2] Immunomodulating therapy (Imids) for multiple myeloma (MM) and myelodysplastic syndromes (MDS)
    Bennett, J. M.
    Wilmot, James P.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 60 : S10 - S10
  • [3] Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers
    Bertolini, F
    Mingrone, W
    Alietti, A
    Ferrucci, PF
    Cocorocchio, E
    Peccatori, F
    Cineri, S
    Mancuso, P
    Corsini, C
    Burlini, A
    Zucca, E
    Martinelli, G
    ANNALS OF ONCOLOGY, 2001, 12 (07) : 987 - 990
  • [4] Myelodysplastic syndrome (MDS) associated with multiple myeloma (MM)
    Podoltseva, EI
    Morosova, EV
    Podoltsev, NA
    Afanasiev, BV
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1142 - 1142
  • [5] Treatment-related myelodysplastic syndromes (t-MDS) after autotransplants (AT) for multiple myeloma (MM).
    Tricot, GJ
    Thertulien, R
    Jacobson, J
    Fassas, A
    Zangari, M
    Anaissie, EJ
    Barlogie, B
    BLOOD, 2002, 100 (11) : 97A - 97A
  • [6] Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers. (vol 12, pg 987, 2001)
    Bertolini, F
    Mingrone, W
    Alietti, A
    Ferrucci, PF
    Cocorocchio, E
    Peccatori, F
    Cinieri, S
    Mancuso, P
    Corsini, C
    Burlini, A
    Zucca, E
    Martinelli, G
    ANNALS OF ONCOLOGY, 2001, 12 (09) : 1333 - 1333
  • [7] The clinical safety of lenalidomide in multiple myeloma and myelodysplastic syndromes
    Palumbo, Antonio
    Freeman, John
    Weiss, Lilia
    Fenaux, Pierre
    EXPERT OPINION ON DRUG SAFETY, 2012, 11 (01) : 107 - 120
  • [8] Combination of thalidomide and Enbrel for the treatment of patients with myelodysplastic syndromes (MDS).
    Raza, A
    Dutt, D
    Lisak, L
    Dean, L
    Fantroy, L
    Gezer, S
    Syed, E
    Goldberg, C
    Loew, J
    Hsu, WT
    Venugopal, P
    BLOOD, 2001, 98 (11) : 273B - 274B
  • [9] Improvement in cytopenias of patients with myelodysplastic syndromes (MDS) in response to thalidomide
    Raza, A
    Lisak, L
    Little, L
    Andrews, C
    Meyer, P
    Ekbal, M
    Venugopal, P
    EXPERIMENTAL HEMATOLOGY, 2000, 28 (07) : 103 - 104
  • [10] Clinical and biological activity of thalidomide (Thal) in multiple myeloma (MM).
    Shima, Y
    Treon, SP
    Yoshizaki, K
    Tai, YT
    Hideshima, T
    Raje, N
    Chauhan, D
    Davies, F
    Schlossman, R
    Anderson, KC
    BLOOD, 1999, 94 (10) : 125A - 125A
12345